These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28899765)

  • 1. Mechanical particle coating using polymethacrylate nanoparticle agglomerates for the preparation of controlled release fine particles: The relationship between coating performance and the characteristics of various polymethacrylates.
    Kondo K; Kato S; Niwa T
    Int J Pharm; 2017 Oct; 532(1):318-327. PubMed ID: 28899765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.
    Kondo K; Ito N; Niwa T; Danjo K
    Int J Pharm; 2013 Sep; 453(2):523-32. PubMed ID: 23796831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance.
    Kondo K; Ando C; Niwa T
    Int J Pharm; 2019 Jan; 554():387-398. PubMed ID: 30513400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binder-free dry particulate coating process using a mild vibration field: Effects of glass-transition temperature and powdering method of polymeric coating agents on coating performance.
    Yasunaga T; Nakamura K; Andoh T; Ichikawa H
    Int J Pharm; 2019 Apr; 561():206-218. PubMed ID: 30822506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solventless-mixing tablet coating technique using a V-shaped blender; investigation using methyl methacrylate and diethylaminoethyl methacrylate copolymer powder.
    Kondo K; Ono K; Ueda A; Niwa T
    Eur J Pharm Biopharm; 2020 Jan; 146():41-54. PubMed ID: 31786323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of the Influences of Processing Conditions on the Properties of Spray Dried Chitosan-Tripolyphosphate Particles loaded with Theophylline.
    Wei Y; Huang YH; Cheng KC; Song YL
    Sci Rep; 2020 Jan; 10(1):1155. PubMed ID: 31980705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing.
    Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T
    Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A statistical approach to optimize the spray drying of starch particles: application to dry powder coating.
    Bilancetti L; Poncelet D; Loisel C; Mazzitelli S; Nastruzzi C
    AAPS PharmSciTech; 2010 Sep; 11(3):1257-67. PubMed ID: 20706878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in fundamental and functional properties of HPMC co-processed fillers prepared by fluid-bed coating and spray drying.
    Dong Q; Zhou M; Lin X; Shen L; Feng Y
    Eur J Pharm Sci; 2018 Jul; 119():147-158. PubMed ID: 29626592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler.
    Salem H; Abdelrahim M; Eid KA; Sharaf M
    Int J Nanomedicine; 2011; 6():311-20. PubMed ID: 21383856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglomerates containing pantoprazole microparticles: modulating the drug release.
    Raffin RP; Colombo P; Sonvico F; Rossi A; Jornada DS; Pohlmann AR; Guterres SS
    AAPS PharmSciTech; 2009; 10(2):335-45. PubMed ID: 19319687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Controlled-Release Fine Particles Using a Dry Coating Method.
    Nakamura S; Sakamoto T; Ito T; Kabasawa K; Yuasa H
    AAPS PharmSciTech; 2016 Dec; 17(6):1393-1403. PubMed ID: 26769346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spheronization mechanism of pharmaceutical material crystals processed by extremely high shearing force using a mechanical powder processor.
    Kondo K; Kido K; Niwa T
    Eur J Pharm Biopharm; 2016 Oct; 107():7-15. PubMed ID: 27368746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and solidification of redispersible nanosuspensions.
    Zhang X; Guan J; Ni R; Li LC; Mao S
    J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.